ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Rigel Pharmaceuticals Inc

Rigel Pharmaceuticals Inc (RIGL)

1.34
-0.02
(-1.47%)
Closed March 18 04:00PM
1.33
-0.01
(-0.75%)
After Hours: 07:52PM

Rigel Pharmaceuticals Inc Financial Summary

The current RIGL market cap is 233.25M. The company's latest EPS is USD -0.3340 and P/E is -4.01.

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 22.41M51.28M26.07M26.89M28.13M
Operating Income -18.4M2.08M-12.73M-5.27M-4.47M
Net Income -19.04M1.4M-13.54M-6.6M-5.69M
Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 44.51M59.29M108.62M149.24M120.24M
Operating Income -72.68M-69.09M-28.97M-12.5M-55.55M
Net Income -70.48M-66.89M-29.74M-17.91M-58.57M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 115.61M134.28M123.61M117.09M115.32M
Total Liabilities 135.44M147.9M147.87M145.21M147.16M
Total Equity -19.83M-13.62M-24.26M-28.12M-31.83M
Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 139.11M147.57M110.38M167.33M134.28M
Total Liabilities 29.23M93.75M76.35M136.95M147.9M
Total Equity 109.88M53.82M34.03M30.37M-13.62M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -51.85M-73.76M-4.07M1.86M497k
Investing 54.18M72.78M777k3.75M2.58M
Financing 8.65M6.55M19.12M18.75M17.88M
Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -58.83M-41.51M-52.19M5.88M-73.76M
Investing 24.96M-23.66M47.47M-80.04M72.78M
Financing 71.89M11.37M12.57M62.68M6.55M
Market Cap 233.25M
Price to Earnings Ratio -4.01
Price to Sales Ratio 1.95
Price to Cash Ratio 9.61
Price to Book Ratio -17.26
Dividend Yield -

Share Statistics

Shares Outstanding 175.38M
Average Volume (1 week) 1.49M
Average Volume (1 Month) 1.64M
52 Week Change -8.28%
52 Week High 1.96
52 Week Low 0.712
Spread (Intraday) 0.05 (3.6%)

Company Info

Company Name Rigel Pharmaceuticals Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.rigel.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com